Harald Ott, a surgeon at Harvard Medical School, thinks that his lab’s unusual methods might someday solve the organ-transplant crisis. On average, 20 people in the United States die every day awaiting donor organs for transplant, according to the American Transplant Foundation. If Ott’s idea works, it could one day eliminate the need for an organ waiting list.
The lab chemically treats organs from rats and pigs to remove all their cells, leaving behind an empty scaffolding. The researchers then populate the scaffold with stem cells from a patient, hoping to create an organ that the human body will accept.
In the most recent work, the lab is using a technique Ott helped develop called lung regeneration, transforming lungs from rats and pigs into human--compatible ones. Though rat lungs aren’t suitable as human transplants, they provide an excellent means to test the regeneration procedure.
Ott originally began to develop this technique while studying at the University of Minnesota (see “Creating a heart”). In the decade since then, his lab has made strides in deciphering the conditions under which stem cells develop into functioning organs.
So far the team has been able to transplant organs re-created with human stem cells back into pigs and rats. Given that the organs have human cells foreign to the animals, they stay alive for only about a week. But the experiments are evidence that these organs can work in a living organism.
Biotechnology and health
What to know about this autumn’s covid vaccines
New variants will pose a challenge, but early signs suggest the shots will still boost antibody responses.
A biotech company says it put dopamine-making cells into people’s brains
The experiment to treat Parkinson’s is a critical early test of stem cells’ potential to tackle serious disease.
Tiny faux organs could crack the mystery of menstruation
Researchers are using organoids to unlock one of the human body’s most mysterious—and miraculous—processes.
How AI can help us understand how cells work—and help cure diseases
A virtual cell modeling system, powered by AI, will lead to breakthroughs in our understanding of diseases, argue the cofounders of the Chan Zuckerberg Initiative.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.